1 mg/ml
Trade Name
Tzield
Solution for injection
Request Type
Registration
Drug Type
Biological Drug
Approval Date
SFDA Approved Use
Teplizumab is indicated to delay the of Stage 3 type 1 diabetes in adults and pediatric patients 8 years of age and older with Stage 2 type 1 diabetes